Mizuho lowered the firm’s price target on Medical Properties Trust (MPW) to $5 from $6 and keeps a Neutral rating on the shares. The firm says that despite healthcare real estate investment trusts’ outperformance in fiscal 2024, it continues to like the subsector into fiscal 2025, but feels “some rotation is warranted. Mizuho reiterates a positive stance on senior housing and shifted to neutral from positive on the skilled nursing facility group. It recommends rotating into life sciences as it sees venture funding improving through the year.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MPW:
- Medical Properties Trust price target lowered to $3 from $3.50 at BofA
- Medical Properties Trust prospect to sell managed care unit to Astrana for $745M
- Medical Properties Trust Reports Q3 2024 Results
- Medical Properties Trust reports Q3 normalized FFO 16c, consensus 20c
- MPW Upcoming Earnings Report: What to Expect?